Gilead Sciences Inc/ US3755581036 /
2024-11-14 6:10:46 PM | Chg. -0.3300 | Volume | Bid6:10:46 PM | Ask6:10:46 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
92.3000USD | -0.36% | 2.46 mill. Turnover: 163.9 mill. |
92.2900Bid Size: 500 | 92.3100Ask Size: 100 | 115.22 bill.USD | 3.25% | 20.36 |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 2,276 | 2,865 | 3,295 | 4,006 | 4,502 | ||||||
Intangible Assets | 10,247 | 8,971 | 17,100 | 15,738 | 13,786 | ||||||
Long-Term Investments | 11,601 | 20,485 | 11,184 | 1,423 | 1,488 | ||||||
Fixed Assets | 27,076 | 36,532 | 38,460 | 27,839 | 31,331 | ||||||
Inventories | 1,955 | 1,587 | 801 | 814 | 922 | ||||||
Accounts Receivable | 5,854 | 4,514 | 3,851 | 3,327 | 3,582 | ||||||
Cash and Cash Equivalents | 12,851 | 8,229 | 7,588 | 17,940 | 11,631 | ||||||
Current Assets | 24,763 | 20,445 | 31,823 | 35,836 | 30,296 | ||||||
Total Assets | 51,839 | 56,977 | 70,283 | 63,675 | 61,627 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,178 | 1,206 | 814 | 790 | 713 | ||||||
Long-term debt | 21,195 | 26,346 | 30,795 | 24,574 | 22,094 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 32,726 | 37,614 | 49,782 | 42,141 | 38,977 | ||||||
Share Capital | 1 | 1 | 1 | 1 | 1 | ||||||
Total Equity | 19,113 | 19,363 | 20,501 | 21,534 | 22,650 | ||||||
Minority Interests | 579 | 476 | 59 | 147 | 125 | ||||||
Total liabilities equity | 51,839 | 56,977 | 70,283 | 63,675 | 61,627 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 32,639 | 30,390 | 26,107 | 22,127 | 22,449 | ||||||
Depreciation (total) | 161 | - | - | - | - | ||||||
Operating Result | 22,193 | 17,633 | 14,124 | 8,200 | 4,287 | ||||||
Interest Income | -688 | -964 | -1,118 | -1,077 | -995 | ||||||
Income Before Taxes | 21,659 | 17,097 | 13,529 | 7,799 | 5,160 | ||||||
Income Taxes | 3,553 | 3,609 | 8,885 | 2,339 | -204 | ||||||
Minority Interests Profit | -2 | -13 | 16 | 5 | -22 | ||||||
Net Income | 18,108 | 13,501 | 4,628 | 5,455 | 5,386 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 20,329 | 16,669 | 11,898 | 8,400 | 9,144 | ||||||
Cash Flow from Investing Activities | -12,475 | -11,985 | -16,069 | 14,355 | -7,817 | ||||||
Cash Flow from Financing | -4,963 | -9,347 | 3,393 | -12,318 | -7,634 | ||||||
Decrease / Increase in Cash | 2,824 | -4,622 | -641 | 10,352 | -6,309 | ||||||
Employees | 8,000 | 9,000 | 10,000 | 11,000 | 11,800 |